COVID-19 Testing – Steve Verschoor

US FDA Approves SDNA Saliva Collection Devices for COVID-19 Testing

Based in Boise, Idaho, Steve Verschoor is an electrical engineering professional with several decades of experience in the field. In addition to his senior role at GTSP Global, Steve Verschoor co-founded Molecular Testing Labs, which performs COVID-19 testing.

The Spectrum Solutions SpectrumDNA SDNA-1000 collection equipment has been authorized in select laboratories by the US FDA. SDNA saliva collection kits guarantee sample uniformity and long-term stability while preserving DNA and RNA transcripts post-collection to assure reliable test findings. Two milliliters of saliva can be stored intact and sent to the lab using this collection kit. This allows laboratories to expand COVID-19 PCR testing and handle up to 8,000 samples in a single day.

Instead of utilizing a throat or nose swab, saliva samples are obtained by spitting into a sample collection kit. Saliva sampling is simple, non-invasive, and more acceptable for repeat testing, and it may be done by non-healthcare professionals or anyone who has been adequately instructed.

COVID-19 Testing for International Travel – Expert Recommendation

An accomplished Boise, Idaho electrical engineering professional with several decades of experience, Steve Verschoor is the head of sales at GTSP Global, which he co-founded in 2006. Additionally, Steve Verschoor is a public health professional who co-founded Molecular Testing Labs (MLT). He is interested in infectious disease preventive measures, including the creation of COVID-19 testing.

The first thing to know about COVID-19 testing for international travel is that most testing standards outside the United States now demand a PCR (polymerase chain reaction) lab test rather than a quick antigen test. Experts are stressing the importance of understanding the difference between the two. While Americans can obtain a rapid test (which does not involve sending a sample to a lab for processing) for re-entry into the United States, few countries accept rapid test results for foreign admission due to its low accuracy and instead require samples to be lab examined.

Due to the Health and Human Services Families First Coronavirus Response Act, Americans can get free PCR testing in their region, and testing is in a lot better place than it was in 2020. While there’s no assurance that PCR test results will be ready in 72 hours, as many destinations now require, the turnaround time for test results is significantly shorter than before. Experts also advise knowing the entrance criteria for foreign travel ahead of time and double-checking them until departure in case of any last-minute changes.

Molecular Facilitated COVID-19 Testing for Nursing Homes

An engineering professional drawing on several decades of experience, Steve Verschoor graduated with a bachelor’s degree in electrical engineering from Keller School of Management in Phoenix, Arizona. In addition, Steve Verschoor co-founded Molecular Testing Labs, where he oversees all sales and business development. The firm provides testing for various contagious diseases, including COVID-19.

Molecular Testing Lab aims to deliver affordable and creative laboratory solutions to private healthcare facilities, universities, payors, and public health organizations through collaborative partnerships. The lab has created a proprietary information system capable of tracking patient specimens for conformity to medical testing rules, revolutionizing access to inexpensive and convenient testing.

Molecular Testing Lab established an accelerated method in 2020 to assist nursing homes in Washington to receive COVID-19 testing kits and be tested. The procedure is simple, and all that is required is for facilities to complete an online registration form on the Molecular website. The registered providers specified received a provider acknowledgment form through “Pandadoc” for electronic signature after finalizing the form. Molecular sends out the specified quantity of collection kits and materials, along with specimen collection instructions, after the acknowledgment form is signed.

Sample Types for COVID-19 Testing

An engineering professional drawing on several decades of experience, Steve Verschoor co-founded GTSP Global Inc., a Boise-based energy firm. Subsequently, Steve Verschoor founded Washington-based Molecular Testing Labs (MTL), an organization focused on the development of protocols and innovative medical testing solutions for the detection of contagious diseases, including COVID-19.

Currently, multiple COVID-19 tests are available which test for either a past or current infection. A serology test, also called an antibody test, tests for past infection, and does not diagnose a current infection. A viral test, on the other hand, can detect a current infection and will be one of two types – an antigen test or a nucleic acid amplification test (NAAT).

Generally, various tests are conducted using fluid samples with the aid of special testing devices. These samples include:

Saliva samples: Rather than using a nose or throat swab, saliva samples are collected using a tube into which a patient provides saliva.

Swab samples: Using a cotton swab, samples are collected from the nose or throat.

Blood samples: Used for antibody tests, blood samples determine if a patient has been infected by the virus in the past. These samples are collected by healthcare professionals.